Please wait while we load the requested 8-K report or click the link below:
https://last10k.com/sec-filings/report/1084966/000143667208000029/avva8kregardingwrittenconsen.htm
August 2011
June 2011
February 2009
November 2008
September 2008
August 2008
July 2008
June 2008
Please wait while we load the requested 8-K report or click the link below:
https://last10k.com/sec-filings/report/1084966/000143667208000029/avva8kregardingwrittenconsen.htm
Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Abviva Inc.
Abviva Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2008 10-K Annual Report includes:
CIK: 1084966Events:
Form Type: 8-K Corporate News
Accession Number: 0001436672-08-000029
Submitted to the SEC: Fri Sep 12 2008 4:51:11 PM EST
Accepted by the SEC: Fri Sep 12 2008
Period: Tuesday, September 9, 2008
Industry: Medical Laboratories